Clinical Outcome of Vitamin D Supplementation in Moderate and Severe COVID-19 Patients: A Randomized Clinical Trial

Authors

  • Sanket Agrawal SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
  • Sushant Meshram SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
  • Shruti Agrawal SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
  • Kamlesh Taori SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS
  • Shubham Biyani SR Respiratory Medicine IGGMC& Mayo Hospital Nagpur, Prof & Head Respiratory Medicine Government Medical College, Nagpur, Psychiatrist Get-well Hospital Nagpur, Gastroenterologist, Bhopal, Resident Physician Department of Neurology, UAMS

DOI:

https://doi.org/10.48165/f1mdjc96

Keywords:

COVID-19, Vitamin D, Supplementation, Clinical Outcomes, Randomized Clinical Trial, Tertiary Care Hospital, Inflammatory Markers, Steroid-Sparing Effect

Abstract

The COVID-19 pandemic has posed a major global health challenge, especially for individuals with underlying health issues. This study aimed to assess the clinical outcomes of vitamin D supplementation in patients with moderate to severe COVID-19 in a tertiary care hospital through a randomized clinical trial. Sixty-two SARS-CoV-2 positive patients were enrolled and divided into intervention (vitamin D supplementation) and control groups.

References

1. World Health Organization. "Coronavirus Disease (COVID-19) Situation Report." 2. Holick, M.F. "Vitamin D deficiency." New England Journal of Medicine, 2007. 3. Grant, W.B., et al. "Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths." Nutrients, 2020.

4. Dong, E.; Du, H.; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020, 20, 533–534.

5. Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513.

6. Yang, J.; Zheng, Y.; Gou, X.; Pu, K.; Chen, Z.; Guo, Q.; Ji, R.;Wang, H.;Wang, Y.; Zhou, Y.-N. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int. J. Infect. Dis. 2020, 94, 91–95. [PubMed]

7. Shi, Y.; Yu, X.; Zhao, H.; Wang, H.; Zhao, R.; Sheng, J. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit. Care 2020, 24, 1–4.

8. Mradul Mohan, Jerin Jose CherianID2, Amit SharmaID1,3 Exploring links between vitamin D deficiency and COVID-19 PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008874 September 18.

9. Alvarez-Rodriguez L, Lopez-Hoyos M, Garcia-Unzueta M,Amado JA, Cacho PM, Martinez-Taboada VM. Age and low levels of circulating vitamin D are associated with impaired innate immune function. J Leukoc Biol. 2012;91(5):829-838.

Downloads

Published

2024-06-27

Issue

Vol. 7 No. 1 (2024): Academia Journal of Medicine(Jan-Jun)

Section

Research Paper

How to Cite

Clinical Outcome of Vitamin D Supplementation in Moderate and Severe COVID-19 Patients: A Randomized Clinical Trial. (2024). Academia Journal of Medicine, 7(1), 86–89. https://doi.org/10.48165/f1mdjc96